Low dose [qnco]
Progesterone therapy [topp]
postmenopausal [tmco]
Women [popg]
effects [qlco]
Plasma lipids [lbpr]
Lipoproteins [aapp, bacs]
Liver function [ortf]
Parameters [fndg]
Cardiovascular disease [dsyn]
Old [tmco]
Women [popg]
Health [idcn]
Problem [fndg]
Leading [tmco]
Group [idcn]
Developed Countries [qlco]
Reduced [qlco]
Estrogen [horm, phsu, strd]
Users [humn]
secondary [neop]
Favorable [qlco]
Lipid [lipd]
Estrogen [horm, phsu, strd]
Concomitant [tmco]
Progestogens [horm, phsu, strd]
Administered [ftcn]
Objective [inpr]
Study [mnob]
effects [qlco]
Novel [tmco]
Hormone replacement therapy [topp]
Regimen [topp]
Liver enzymes [aapp, enzy]
Lipids [lipd]
Lipoproteins [aapp, bacs]
postmenopausal [tmco]
Women [popg]
Design [acty]
prospective [resa]
Open [spco]
Trial [resa]
months [tmco]
Methods [inpr]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Age [orga]
Received [qlco]
mg% [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Daily [tmco]
mg% [qnco]
Oral [spco]
Progesterone [horm, phsu, strd]
days [tmco]
Calendar [tmco]
months [tmco]
interruption [ftcn]
Main [qlco]
outcome measure [qnco]
Gonadotrophins, NOS [aapp, horm, phsu]
Liver function [ortf]
Parameters [fndg]
Lipoproteins [aapp, bacs]
Measured [qlco]
treatment [ftcn]
months [tmco]
treatment [ftcn]
Compliance [qnco]
treatment [ftcn]
confirmed [qlco]
Decrease [qlco]
Follicle Stimulating Hormone [aapp, horm, phsu]
End [spco]
treatment [ftcn]
Same [qlco]
serum cholesterol [lbpr]
ldl hdl ratio [lbtr]
Decreased [qnco]
baseline [bodm]
Levels [qlco]
Percentage [qnco]
Triglycerides [bacs, lipd]
Basal [spco]
Levels [qlco]
Progesterone [horm, phsu, strd]
Progesterone [horm, phsu, strd]
Near [fndg]
Continuous [idcn]
Administration [ocac]
Fixed [fndg]
Low dose [qnco]
Progesterone [horm, phsu, strd]
adverse effects [ftcn]
Lipid [lipd]
postmenopausal [tmco]
Women [popg]
Combined [qlco]
Continuous [idcn]
Estrogen Replacement Therapy [topp]
Women [popg]
Borderline [qlco]
Excluded [idcn]
